Unlike RIPK3 and MLKL, RIPK1 has been identified as a central driver of inflammation in atherosclerosis by promoting the release of inflammatory cytokines through the NF‐κB pathway, which is independent of necroptosis‐associated pathways.47 This evidence concerns the gene RIPK3 and atherosclerosis.